Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice. - Archive ouverte HAL Access content directly
Journal Articles International Journal of Pharmaceutics Year : 2012

Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice.

(1) , (1) , (1) , (1) , (1) , (1) , (1)
1

Abstract

The natural flavonoid fisetin (3,3',4',7-tetrahydroxyflavone) has shown antitumour activity but its administration is complicated by its low water solubility. Our aim was to incorporate fisetin into a nanoemulsion to improve its pharmacokinetics and therapeutic efficacy. Solubility and emulsification tests allowed to develop an optimal nanoemulsion composed of Miglyol 812N/Labrasol/Tween 80/Lipoid E80/water (10%/10%/2.5%/1.2%/76.3%). The nanoemulsion had an oil droplet diameter of 153 ± 2 nm, a negative zeta potential (-28.4 ± 0.6 mV) and a polydispersity index of 0.129. The nanoemulsion was stable at 4 °C for 30 days, but phase separation occurred at 20 °C. Pharmacokinetic studies in mice revealed that the fisetin nanoemulsion injected intravenously (13 mg/kg) showed no significant difference in systemic exposure compared to free fisetin. However, when the fisetin nanoemulsion was administered intraperitoneally, a 24-fold increase in fisetin relative bioavailability was noted, compared to free fisetin. Additionally, the antitumour activity of the fisetin nanoemulsion in Lewis lung carcinoma bearing mice occurred at lower doses (36.6 mg/kg) compared to free fisetin (223 mg/kg). In conclusion, we have developed a stable nanoemulsion of fisetin and have shown that it could improve its relative bioavailability and antitumour activity.
Fichier principal
Vignette du fichier
Ragelle_et_al_accepted_IJP_2012-_Copie.pdf (634.75 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00709735 , version 1 (19-06-2012)

Identifiers

Cite

Héloïse Ragelle, Sylvie Crauste-Manciet, Johanne Seguin, Denis Brossard, Daniel Scherman, et al.. Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice.. International Journal of Pharmaceutics, 2012, 427 (2), pp.452-9. ⟨10.1016/j.ijpharm.2012.02.025⟩. ⟨inserm-00709735⟩
570 View
3392 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More